News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,051 Results
Type
Article (39473)
Company Profile (284)
Press Release (649294)
Section
Business (204163)
Career Advice (1998)
Deals (35411)
Drug Delivery (89)
Drug Development (81068)
Employer Resources (168)
FDA (16119)
Job Trends (14823)
News (345159)
Policy (32510)
Tag
Academia (2540)
Alliances (49277)
Alzheimer's disease (1260)
Approvals (16067)
Artificial intelligence (144)
Bankruptcy (353)
Best Places to Work (11588)
Biotechnology (200)
Breast cancer (188)
Cancer (1370)
Cardiovascular disease (112)
Career advice (1666)
Cell therapy (282)
Clinical research (64853)
Collaboration (485)
Compensation (260)
COVID-19 (2545)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6178)
Earnings (84937)
Employer resources (146)
Events (110149)
Executive appointments (394)
FDA (16788)
Funding (426)
Gene therapy (195)
GLP-1 (601)
Government (4339)
Healthcare (18715)
Infectious disease (2637)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16345)
Job creations (3633)
Job search strategy (1420)
Layoffs (420)
Legal (7873)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13226)
Medtech (13231)
Mergers & acquisitions (19223)
Metabolic disorders (452)
Neuroscience (1582)
NextGen Class of 2024 (6534)
Non-profit (4469)
Northern California (1695)
Obesity (258)
Opinion (185)
Patents (117)
People (56513)
Phase I (20181)
Phase II (28577)
Phase III (21277)
Pipeline (518)
Postmarket research (2566)
Preclinical (8574)
Radiopharmaceuticals (241)
Rare diseases (264)
Real estate (5902)
Regulatory (21711)
Research institute (2319)
Resumes & cover letters (349)
Southern California (1462)
Startups (3577)
United States (15149)
Vaccines (565)
Weight loss (181)
Date
Today (33)
Last 7 days (582)
Last 30 days (2422)
Last 365 days (35254)
2024 (35057)
2023 (40136)
2022 (51255)
2021 (55759)
2020 (54129)
2019 (46612)
2018 (35074)
2017 (32183)
2016 (31549)
2015 (37598)
2014 (31369)
2013 (26407)
2012 (28622)
2011 (29300)
2010 (27372)
Location
Africa (714)
Arizona (195)
Asia (37409)
Australia (6125)
California (3812)
Canada (1449)
China (305)
Colorado (171)
Connecticut (176)
Europe (80079)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2962)
Michigan (172)
Minnesota (290)
New Jersey (1101)
New York (1081)
North Carolina (743)
Northern California (1695)
Ohio (146)
Pennsylvania (923)
South America (1094)
Southern California (1462)
Texas (547)
Utah (108)
Washington State (399)
689,051 Results for "alpha genesis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves AChEI ALPHA-1062 for Alzheimer’s Disease Treatment
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.
August 2, 2024
·
2 min read
Press Releases
Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
December 11, 2024
·
4 min read
Press Releases
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals
October 24, 2024
·
5 min read
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
Press Releases
Radon Medical Imaging Announces Acquisition of Alpha Imaging
November 19, 2024
·
5 min read
Press Releases
Targeted Alpha Therapy Market Clinical Trials Proprietary Technologies Insight
December 12, 2024
·
1 min read
Business
Alpha Cognition Announces First Quarter of 2024 Results and Provides Corporate Update
Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, reported financial results for the first quarter of 2024 and provided a corporate update.
May 14, 2024
·
7 min read
Biotech Beach
Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women’s Healthcare
Women’s health innovator Evofem Biosciences, Inc. announced a new market partnership with Hello Alpha, a telemedicine company with a medical team specifically trained for a woman’s unique needs, to offer Phexxi®, the non-hormonal prescription vaginal gel FDA-approved to prevent pregnancy for those who choose to use an on-demand method of birth control.
June 27, 2024
·
4 min read
Alpha Tau to Participate in May 2024 Investor Conferences
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.
May 1, 2024
·
1 min read
Press Releases
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
December 6, 2024
·
1 min read
1 of 68,906
Next
